Search Results - "Roch, B."

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients by Cervera, R, Khamashta, M A, Shoenfeld, Y, Camps, M T, Jacobsen, S, Kiss, E, Zeher, M M, Tincani, A, Kontopoulou-Griva, I, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G, Gromnica-Ihle, E, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quéré, I, Hachulla, E, Vasconcelos, C, Roch, B, Fernández-Nebro, A, Piette, J-C, Espinosa, G, Bucciarelli, S, Pisoni, C N, Bertolaccini, M L, Boffa, M-C, Hughes, G R V

“…To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and…”
Get more information

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 by Besse, B., Felip, E., Garcia Campelo, R., Cobo, M., Mascaux, C., Madroszyk, A., Cappuzzo, F., Hilgers, W., Romano, G., Denis, F., Viteri, S., Debieuvre, D., Galetta, D., Baldini, E., Razaq, M., Robinet, G., Maio, M., Delmonte, A., Roch, B., Masson, P., Schuette, W., Zer, A., Remon, J., Costantini, D., Vasseur, B., Dziadziuszko, R., Giaccone, G., Zemanová, M., Besse, B., Bonnet, C., Cadranel, J., Chouaid, C., Cortot, A., Debieuvre, D., Delclaux, B., Denis, F., Duchemann, B., El Kouri, C., Ferrand, F.R., Ginoux, M., Hilgers, W., Madroszyk, A., Masson, P., Mazieres, J., Molinier, O., Moro-Sibilot, D., Pichon, E., Mascaux, C., Robinet, G., Roch, B., Zalcman, G., Schmidtke-Schrezenmeier, G., Schuette, W., Urban, L., Gottfried, M., Nechushtan, H., Peled, N., Wollner, M., Zer, A., Baldini, E., Bonanno, L., Bonetti, A., Cappuzzo, F., Delmonte, A., Galetta, D., Maio, M., Minotti, V., Rea, A., Romano, G., Tassinari, D., Tonini, G., Dziadziuszko, R., Karaszewska, B., Szczęsna, A., Cobo, M., De Castro, J., Felip, E., Garcia Campelo, M.R., Hernández, A., Moran, T., Provencio, M., Viteri, S., Dasgupta, A., Gabrail, N., Giaccone, G., Harshad, A., Liu, S., Oubre, D., Panikkar, R., Razaq, M., Sanborn, R.

“…Patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint blockers (ICBs) ultimately progress either rapidly (primary…”
Get full text

Small cell lung cancer and immuno-oncologic agents: End of the cisplatin - etoposide era? by Pujol, J L, Roch, B

“…In the setting of small cell lung cancer (SCLC), the development of immuno-oncological agents, particularly those targeting Programmed cell Death protein 1…”
Get more information

Authors reply to letter to the editor by Dr Degens et al by Bommart, S., Pujol, J.-L., Coffy, A., Daurès, J.-P., Roch, B.

Get full text

Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis by Cortey, A, Elzaabi, M, Waegemans, T, Roch, B, Aujard, Y

“…ABO fetomaternal red blood cell incompatibility (ABO FMI) induces an immune hemolysis after fetal transfer of hemolyzing maternal anti-A or anti-B. ABO…”
Get full text

Differences in Emotion Processing in Patients With Essential and Secondary Hypertension by Consoli, Silla M., Lemogne, Cédric, Roch, Bernard, Laurent, Stéphane, Plouin, Pierre-François, Lane, Richard D.

“…Background An impaired ability to experience and express emotions, known as alexithymia, has previously been associated with hypertension. Alexithymia and…”
Get full text

What do chemotherapy specialists expect of lung cancer? by Pujol, J-L, Roch, B, Coffy, A, Mérel, J-P, Daurès, J-P

“…In an attempt to understand physicians' expectations of chemotherapy, a group of lung cancer specialists was involved in an online survey investigating their…”
Get more information

Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study by Girard, N., Galland-Girodet, S., Avrillon, V., Besse, B., Duruisseaux, M., Cadranel, J., Otto, J., Prevost, A., Roch, B., Bennouna, J., Bouledrak, K., Coudurier, M., Egenod, T., Lamy, R., Ricordel, C., Moro-Sibilot, D., Odier, L., Tillon-Strozyk, J., Zalcman, G., Missy, P., Westeel, V., Baldacci, S.

“…ROS1-rearranged (ROS1+) non-small-cell lung cancer (NSCLC) is a rare lung cancer with limited treatment options. Phase I-II studies with ROS1-tyrosine kinase…”
Get full text

A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care - the LASER-AD Study by Livingston, G., Katona, C., Roch, B., Guilhaume, C., Rive, B.

“…SUMMARY Background: Loss of independence becomes more marked as Alzheimer's disease (AD) progresses and contributes significantly to its societal and economic…”
Get full text

Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor α as a new therapeutic option by Tausche, A K, Richter, K, Grässler, A, Hänsel, S, Roch, B, Schröder, H E

Get full text

Selective local tone mapping by Artusi, A., Akyuz, A. O., Roch, B., Michael, D., Chrysanthou, Y., Chalmers, A.

“…When preparing high dynamic range images (HDR) for display on standard monitors, it is often necessary to make a choice between global and local tone mapping…”
Get full text

Efficacité et tolérance des immunoglobulines polyvalentes dans l’hyperbilirubinémie néonatale par incompatibilité ABO. Méta-analyse by Cortey, A., Elzaabi, M., Waegemans, T., Roch, B., Aujard, Y.

“…L’incompatibilité fœto-maternelle érythrocytaire (IFME) ABO induit une immuno-hémolyse. Elle est la cause la plus fréquente des hyperbilirubinémies sévères et…”
Get full text

Anti-midbody antibodies as a possible predictive factor for a special limited or abortive form of systemic sclerosis? by Tausche, A K, Conrad, K, Seidel, W, Roch, B

Get full text

Long-term cyclosporin A in systemic sclerosis by Roch, B, Wollina, U, Schroeder, H-E

Get full text

MSR8 Revolutionizing Drug Discovery and Preclinical Research Via Artificial Intelligence: A Targeted Literature Review by Louhichi, KE, Abdelghani, I, Jdidi, H, Boukhris, Y, Roch, B, François, C, Toumi, M, Bakhutashvili, A

Get full text

Do exercise-based prevention programmes reduce non-contact musculoskeletal injuries in football (soccer)? A systematic review and meta-analysis with 13 355 athletes and more than 1 million exposure hours by Lemes, Italo Ribeiro, Pinto, Rafael Zambelli, Lage, Vitor N, Roch, Bárbara A B, Verhagen, Evert, Bolling, Caroline, Aquino, Cecilia Ferreira, Fonseca, Sérgio T, Souza, Thales R

“…The aim of this systematic review was to investigate the effect of exercise-based programmes in the prevention of non-contact musculoskeletal injuries among…”
Get more information

Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients by Cervera, Ricard, Piette, Jean‐Charles, Font, Josep, Khamashta, Munther A., Shoenfeld, Yehuda, Camps, María Teresa, Jacobsen, Soren, Lakos, Gabriella, Tincani, Angela, Kontopoulou‐Griva, Irene, Galeazzi, Mauro, Meroni, Pier Luigi, Derksen, Ronald H. W. M., de Groot, Philip G., Gromnica‐Ihle, Erika, Baleva, Marta, Mosca, Marta, Bombardieri, Stefano, Houssiau, Frédéric, Gris, Jean‐Christophe, Quéré, Isabelle, Hachulla, Eric, Vasconcelos, Carlos, Roch, Beate, Fernández‐Nebro, Antonio, Boffa, Marie‐Claire, Hughes, Graham R. V., Ingelmo, Miguel

“…Objective To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of…”
Get full text

1010P Assessment of early resistance mechanisms to first-line osimertinib in EGFR-mutant NSCLC using spatial transcriptomics by Ruiz de Garibay, G., Roch, B., Garrido Lopez, P., Isla, D., Aguado, C., Callejo Perez, A., Marse Fabregat, R., Garcia Campelo, M.R., Blasco Cordellat, A., Sanchez Torres, J.M., Bernabe Caro, R., Juan Vidal, O.J., De Castro Carpeno, J., Franco, F.F., Ramos Garcia, I., Gomez Rueda, A., Conde Gallego, E., Ponce Aix, S., Paz-Ares, L., Zugazagoitia, J.

Get full text

Temporomandibular dysfunction and dysphonia (TMD) by Piron, A, Roch, J B

“…Freedom of the manducatory apparatus is critical to economical and accurate vocal production. Two types of dysfunction will be discussed: global muscular…”
Get more information

Concomitant activation of Cl- and K+ currents by secretory stimulation in human epithelial cells by Baró, I, Roch, B, Hongre, A S, Escande, D

“…1. Whole-cell currents were investigated in the model salt-secreting epithelium, human T84 cell line, by means of the perforated patch-clamp technique. In the…”
Get full text